Log In
BCIQ
Print this Print this
 

Sublingual MPL

  Manage Alerts
Collapse Summary General Information
Company Allergy Therapeutics plc
DescriptionSublingual vaccine with monophosphoryl lipid A (MPL)
Molecular Target
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAllergy
Indication DetailsTreat allergy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today